Dr. Reddy’s Launches Generic Cymbalta

Dr. Reddy’s Laboratories announced the launch of Duloxetine Delayed-Release Capsules, the generic version of Eli Lilly’s Cymbalta.

Duloxetine is a serotonin and norepinephrine reuptake inhibitor indicated for generalized anxiety disorder, fibromyalgia, major depressive disorder, chronic musculoskeletal pain (eg, low back pain, osteoarthritis pain), and diabetic peripheral neuropathic pain. The exact mechanisms of duloxetine are unknown but they are believed to be related to the potentiation of serotonergic and noradrenergic activity in the CNS.

RELATED: Psychotropic Drug Indications

Duloxetine Delayed-Release Capsules are available in 20mg, 30mg, and 60mg strengths in several bottle counts.

For more information call (866) 733-3952 or visit DrReddys.com.